论文信息 - 2‐(4‐Methylbenzoyloxymethyl)‐5‐(5‐methyl‐2,4‐dioxo‐1,2,3,4‐tetrahydropyrimidin‐1‐yl)tetrahydrofuran‐3‐yl 4‐methylbenzoate

2‐(4‐Methylbenzoyloxymethyl)‐5‐(5‐methyl‐2,4‐dioxo‐1,2,3,4‐tetrahydropyrimidin‐1‐yl)tetrahydrofuran‐3‐yl 4‐methylbenzoate

The title compound, C26H26N2O7, is a thiamidine derivative. Geometric parameters are in the usual ranges. The crystal packing is stabilized by a classical N - H center dot center dot center dot O hydrogen bond, several weak C - H center dot center dot center dot O hydrogen bonds and a pi - pi stacking interaction.

A. N. Mayekar | M. Bolte | H. Yathirajan | B. Narayana | B. Sarojini

[1] Jie Luo,et al. Retrieval of Crystallographically-Derived Molecular Geometry Information , 2004, J. Chem. Inf. Model..

[2] Maria Cristina Burla,et al. SIR2002: the program , 2003 .

[3] E. Clercq. HIV resistance to reverse transcriptase inhibitors , 1994 .

[4] H. Mitsuya,et al. Molecular targets for AIDS therapy. , 1990, Science.

[5] H. Mitsuya,et al. Clinical pharmacology of 3'-azido-2',3'-dideoxythymidine (zidovudine) and related dideoxynucleosides. , 1989, The New England journal of medicine.

2‐(4‐Methyl­benzoyl­oxymeth­yl)‐5‐(5‐methyl‐2,4‐dioxo‐1,2,3,4‐tetra­hydro­pyrimidin‐1‐yl)tetra­hydro­furan‐3‐yl 4‐methyl­benzoate

2‐(4‐Methylbenzoyloxymethyl)‐5‐(5‐methyl‐2,4‐dioxo‐1,2,3,4‐tetrahydropyrimidin‐1‐yl)tetrahydrofuran‐3‐yl 4‐methylbenzoate